Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol: a promising drug for neurodegenerative disorders?
Iuvone T, Esposito G, De Filippis D, Scuderi C, Steardo L. Iuvone T, et al. CNS Neurosci Ther. 2009 Winter;15(1):65-75. doi: 10.1111/j.1755-5949.2008.00065.x. CNS Neurosci Ther. 2009. PMID: 19228180 Free PMC article. Review.
Nevertheless, among Cannabis compounds, cannabidiol (CBD), which lacks any unwanted psychotropic effect, may represent a very promising agent with the highest prospect for therapeutic use....
Nevertheless, among Cannabis compounds, cannabidiol (CBD), which lacks any unwanted psychotropic effect, may represent a very promisi …
Cannabidiol: a prion therapy for mice?
Dicou E. Dicou E. J Neurosci Res. 2008 May 1;86(6):1417-8. doi: 10.1002/jnr.21694. J Neurosci Res. 2008. PMID: 18338806 No abstract available.
Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.
Dirikoc S, Priola SA, Marella M, Zsürger N, Chabry J. Dirikoc S, et al. J Neurosci. 2007 Sep 5;27(36):9537-44. doi: 10.1523/JNEUROSCI.1942-07.2007. J Neurosci. 2007. PMID: 17804615 Free PMC article.
Prion diseases are transmissible neurodegenerative disorders characterized by the accumulation in the CNS of the protease-resistant prion protein (PrPres), a structurally misfolded isoform of its physiological counterpart PrPsen. Both neuropathogenesis and prion
Prion diseases are transmissible neurodegenerative disorders characterized by the accumulation in the CNS of the protease-resistant
Feedback